Edwardteach wrote..

The fact that it's observable across multiple manufacturers indicated that it's more than a manufacturing ****up. It's a problem with the premise itself, which cannot be corrected.

It could be a problem with the premise (delivery of spike protein using messenger RNA) but if that were the case, wouldn't this be seen across a larger number of lots?

Couldn't it just as easily be chalked up to the fact that:

A.) The drug companies don't know what dose to use so they delivered some with extremely high doses (that kill), medium level doses (that injure but don't immediately kill), and some that do nothing thus providing no or limited protection.

B.) The process involved with manufacturing this therapeutic is fragile with narrow tolerances. And if there isn't a way (or desire) to keep the process within that tolerance, then we might see wildly different results once in the arms of the public.

Now, I'm not saying the basic premise underlying the vax is not flawed as well, just on the observation that they don't work as an inoculation against disease. So we have two issues. One about effectiveness and one regarding safety. The safety issue can be further categorized to things like adverse reactions - both short and long term, OAS and ADE, and so on.

At this point anyone who claims the vax is "safe and effective" is either played or paid.

----------